A new CAR-T therapy shows efficacy in preclinical models of hard-to-treat leukemias
Researchers from Clínic-IDIBAPS, within the Clínic Barcelona Comprehensive Cancer Center, and the spin-off Gyala Therapeutics have coordinated a st...
Researchers from Clínic-IDIBAPS, within the Clínic Barcelona Comprehensive Cancer Center, and the spin-off Gyala Therapeutics have coordinated a st...
Researchers from Clínic-IDIBAPS, within the framework of the Clínic Barcelona Comprehensive Cancer Center, have led a study analyzing how genetic m...
An international team led by the Clínic-IDIBAPS and the Institute of Cancer Research in London has developed an innovative new method based on DNA...
The Clínic Barcelona Comprehensive Cancer Center (4CB), driven by Hospital Clínic Barcelona, IDIBAPS, and the University of Barcelona, has announce...
Researchers from the Clínic Barcelona Comprehensive Cancer Center—driven by Hospital Clínic Barcelona, IDIBAPS, and the University of Barcelona—tog...
The European Society for Medical Oncology (ESMO) has published a new clinical practice guideline for the diagnosis, treatment, and follow-up of hep...
The Clínic Barcelona Comprehensive Cancer Center (4CB), driven by Hospital Clínic, IDIBAPS, and the University of Barcelona, strengthens its intern...
The creation of the Clínic Barcelona Comprehensive Cancer Center represents a step forward in the integration of care, clinical research, translati...